Abstract
Children and young adults with potentially lethal cardiac channelopathies often present to medical care with a history of syncope or seizures due to episodic ventricular arrhythmias and associated cerebral hypoperfusion. Catecholaminergic polymorphic ventricular tachycardia is discussed using relevant case example. The pathophysiology and distinguishing clinical features of this condition is reviewed. Cardiac channelopathies can be misdiagnosed as refractory epilepsy when in fact these events represent convulsive syncopes. Knowledge of and suspicion for these arrhythmogenic conditions may improve diagnosis and outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Liu N, Ruan Y, Priori SG (2008) Catecholaminergic polymorphic ventricular tachycardia. Prog Cardiovasc Dis 51:23–30
Mohamed U, Napolitano C, Priori SG (2007) Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol 18:791–797
Napolitano C, Priori SG (2007) Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 4:675–678
Ylanen K, Poutanen T, Hiippala A et al (2010) Catecholaminergic polymorphic ventricular tachycardia. Eur J Pediatr 169:535–542
Wehrens XH (2007) The molecular basis of catecholaminergic polymorphic ventricular tachycardia: what are the different hypotheses regarding mechanisms? Heart Rhythm 4:794–797
Gyorke S (2009) Molecular basis of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 6:123–129
Baher AA, Uy M, Xie F et al (2011) Bidirectional ventricular tachycardia: ping pong in the His-Purkinje system. Heart Rhythm 8:599–605
Tsuboi M, Antzelevitch C (2006) Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7). Heart Rhythm 3:328–335
Van der Werf C, Kannankeril PJ, Sacher F et al (2011) Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol 57(22):2244–2254
Hwang HS, Hasdemir C, Laver D et al (2011) Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol 4:128–135
Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(10):e385–e484
Sy RW, Gollob MH, Klein GJ et al (2011) Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 8:864–871
Zipes DP, Ackerman MJ, Estes NA III et al (2005) Task Force 7: arrhythmias. J Am Coll Cardiol 45:1354–1363
Ackerman MJ, Priori SG, Willems S et al (2011) HRS/EHRA expert consensus statement on the State of Genetic Testing for the channelopathies and cardiomyopathies. Heart Rhythm 8:1308–1339
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Cipolletta, L. (2015). Catecholaminergic Polymorphic Ventricular Tachycardia: A Challenging Case of “Epilepsy”. In: Capucci, A. (eds) Clinical Cases in Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-319-19926-9_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-19926-9_26
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19925-2
Online ISBN: 978-3-319-19926-9
eBook Packages: MedicineMedicine (R0)